KRT33B

gene
On this page

Also known as Ha-3II

Summary

KRT33B (keratin 33B, HGNC:6451) is a protein-coding gene on chromosome 17q21.2, encoding Keratin, type I cuticular Ha3-II (Q14525).

This gene encodes a member of the keratin gene family. This gene is one of multiple type I hair keratin genes that are clustered in a region of chromosome 17q12-q21 and have the same direction of transcription. As a type I hair keratin, the encoded protein is an acidic protein which heterodimerizes with type II keratins to form hair and nails. There are two isoforms of this protein, encoded by two separate genes, keratin 33A and keratin 33B.

Source: NCBI Gene 3884 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 85 total
  • MANE Select transcript: NM_002279

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:6451
Approved symbolKRT33B
Namekeratin 33B
Location17q21.2
Locus typegene with protein product
StatusApproved
AliasesHa-3II
Ensembl geneENSG00000131738
Ensembl biotypeprotein_coding
OMIM602762
Entrez3884

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000251646

RefSeq mRNA: 1 — MANE Select: NM_002279 NM_002279

CCDS: CCDS11389

Canonical transcript exons

ENST00000251646 — 7 exons

ExonStartEnd
ENSE000018105854136349841363953
ENSE000024383814136940341369813
ENSE000024581054136517541365300
ENSE000024860344136790841367990
ENSE000024912524136477941364999
ENSE000025177624136539241365553
ENSE000025281824136647041366626

Expression profiles

Bgee: expression breadth broad, 59 present calls, max score 48.94.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0502 / max 12.5852, expressed in 29 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1658890.050229

Top tissues by expression

112 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
prefrontal cortexUBERON:000045148.94gold quality
anterior cingulate cortexUBERON:000983546.85gold quality
frontal cortexUBERON:000187044.13gold quality
sural nerveUBERON:001548843.13gold quality
skin of abdomenUBERON:000141642.69gold quality
zone of skinUBERON:000001442.18gold quality
skin of legUBERON:000151142.05gold quality
cerebral cortexUBERON:000095641.81gold quality
Brodmann (1909) area 9UBERON:001354040.95gold quality
cortical plateUBERON:000534340.23gold quality
dorsolateral prefrontal cortexUBERON:000983439.94gold quality
lower esophagus mucosaUBERON:003583439.39gold quality
right lungUBERON:000216738.95gold quality
esophagus mucosaUBERON:000246937.40silver quality
right frontal lobeUBERON:000281037.23silver quality
colonic epitheliumUBERON:000039737.20gold quality
vaginaUBERON:000099637.20gold quality
cerebellumUBERON:000203736.95gold quality
cerebellar cortexUBERON:000212936.94gold quality
cerebellar hemisphereUBERON:000224536.74gold quality
right hemisphere of cerebellumUBERON:001489036.71gold quality
Ammon’s hornUBERON:000195436.37gold quality
bone marrow cellCL:000209236.16gold quality
hindlimb stylopod muscleUBERON:000425235.62gold quality
granulocyteCL:000009435.60gold quality
ganglionic eminenceUBERON:000402335.49gold quality
brainUBERON:000095533.62gold quality
minor salivary glandUBERON:000183033.41gold quality
skeletal muscle tissueUBERON:000113433.38gold quality
saliva-secreting glandUBERON:000104433.03gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.18

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

15 targeting KRT33B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-211099.9666.681930
HSA-MIR-450B-5P99.9271.483175
HSA-MIR-548M99.7068.871749
HSA-MIR-1251-3P99.6467.211408
HSA-MIR-561-3P99.6470.903647
HSA-MIR-7156-5P99.6468.811369
HSA-MIR-6852-5P99.1766.692073
HSA-MIR-312599.1468.492269
HSA-MIR-391698.9968.042155
HSA-MIR-6859-5P98.9968.072049
HSA-MIR-450A-2-3P97.9167.561459
HSA-MIR-410-5P96.5566.28459
HSA-MIR-59196.2968.16611
HSA-MIR-323B-5P96.1266.39472
HSA-MIR-494-5P95.3166.29463

Cross-species orthologs

0 orthologs

Paralogs (68): KRT33A (ENSG00000006059), VIM (ENSG00000026025), KRT31 (ENSG00000094796), NEFM (ENSG00000104722), KRT23 (ENSG00000108244), KRT37 (ENSG00000108417), KRT32 (ENSG00000108759), KRT18 (ENSG00000111057), LMNB1 (ENSG00000113368), KRT36 (ENSG00000126337), KRT17 (ENSG00000128422), GFAP (ENSG00000131095), KRT34 (ENSG00000131737), NES (ENSG00000132688), PRPH (ENSG00000135406), KRT85 (ENSG00000135443), KRT7 (ENSG00000135480), KRT71 (ENSG00000139648), INA (ENSG00000148798), LMNTD1 (ENSG00000152936), LMNA (ENSG00000160789), KRT84 (ENSG00000161849), KRT82 (ENSG00000161850), KRT80 (ENSG00000167767), KRT1 (ENSG00000167768), KRT24 (ENSG00000167916), KRT8 (ENSG00000170421), KRT78 (ENSG00000170423), KRT86 (ENSG00000170442), KRT75 (ENSG00000170454), KRT6C (ENSG00000170465), KRT4 (ENSG00000170477), KRT74 (ENSG00000170484), KRT72 (ENSG00000170486), KRT83 (ENSG00000170523), BFSP2 (ENSG00000170819), KRT19 (ENSG00000171345), KRT15 (ENSG00000171346), KRT38 (ENSG00000171360), KRT13 (ENSG00000171401)

Protein

Protein identifiers

Keratin, type I cuticular Ha3-IIQ14525 (reviewed: Q14525)

Alternative names: Hair keratin, type I Ha3-II, Keratin-33B

All UniProt accessions (1): Q14525

UniProt curated annotations — full annotation on UniProt →

Miscellaneous. There are two types of hair/microfibrillar keratin, I (acidic) and II (neutral to basic).

Similarity. Belongs to the intermediate filament family.

RefSeq proteins (1): NP_002270* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR002957Keratin_IFamily
IPR018039IF_conservedConserved_site
IPR039008IF_rod_domDomain

Pfam: PF00038

UniProt features (11 total): region of interest 7, chain 1, domain 1, sequence conflict 1, site 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q14525-F180.400.61

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Catalytic / active sites (1): 305 (stutter)

Function

Pathways and Gene Ontology

Reactome pathways

3 pathways

IDPathway
R-HSA-6805567Keratinization
R-HSA-6809371Formation of the cornified envelope
R-HSA-1266738Developmental Biology

MSigDB gene sets: 83 (showing top): GOBP_MORPHOGENESIS_OF_AN_EPITHELIUM, GOBP_EPITHELIUM_DEVELOPMENT, MORF_FLT1, GOBP_INTERMEDIATE_FILAMENT_BASED_PROCESS, GOBP_INTERMEDIATE_FILAMENT_ORGANIZATION, ENK_UV_RESPONSE_KERATINOCYTE_UP, MARTINEZ_RB1_TARGETS_DN, MODULE_298, MODULE_157, GOBP_MOLTING_CYCLE, NRF2_Q4, MORF_ETV3, TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA, GOBP_TISSUE_MORPHOGENESIS, MODULE_104

GO Biological Process (4): morphogenesis of an epithelium (GO:0002009), epithelial cell differentiation (GO:0030855), hair cycle (GO:0042633), intermediate filament organization (GO:0045109)

GO Molecular Function (3): structural constituent of skin epidermis (GO:0030280), structural molecule activity (GO:0005198), protein binding (GO:0005515)

GO Cellular Component (6): obsolete extracellular space (GO:0005615), cytosol (GO:0005829), cytoskeleton (GO:0005856), keratin filament (GO:0045095), extracellular exosome (GO:0070062), intermediate filament (GO:0005882)

Reactome top-level categories

Rollup of top-2 pathways:

CategoryPathways
Developmental Biology1
Keratinization1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
epithelium development2
tissue morphogenesis1
cell differentiation1
molting cycle1
intermediate filament cytoskeleton organization1
supramolecular fiber organization1
structural molecule activity1
molecular_function1
binding1
cytoplasm1
cellular anatomical structure1
intracellular membraneless organelle1
intermediate filament1
extracellular vesicle1
intermediate filament cytoskeleton1
polymeric cytoskeletal fiber1

Protein interactions and networks

STRING

684 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
KRT33BKRTAP3-1Q9BYR8489
KRT33BKRTAP3-2Q9BYR7466
KRT33BC22orf31O95567446
KRT33BKRTAP3-3Q9BYR6434
KRT33BKRTAP9-3Q9BYQ3431
KRT33BKRTAP13-1Q8IUC0411
KRT33BTEX19Q8NA77403
KRT33BKRTAP9-4Q9BYQ2399
KRT33BTCHHQ07283394
KRT33BSECTM1Q8WVN6377
KRT33BKRTAP13-3Q3SY46353
KRT33BZNF664Q8N3J9337
KRT33BHERC2O95714333
KRT33BKRTAP11-1Q8IUC1330
KRT33BARL5CA6NH57316
KRT33BPRR9Q5T870316

IntAct

286 interactions, top by confidence:

ABTypeScore
KRT4KRT33Bpsi-mi:“MI:0915”(physical association)0.780
KRT33BKRT79psi-mi:“MI:0915”(physical association)0.780
KRT79KRT33Bpsi-mi:“MI:0915”(physical association)0.780
KRT33BKRT4psi-mi:“MI:0915”(physical association)0.780
KRT1KRT33Bpsi-mi:“MI:0915”(physical association)0.740
HGSKRT33Bpsi-mi:“MI:0915”(physical association)0.720
KRT33BNUP58psi-mi:“MI:0915”(physical association)0.720
KDM1AKRT33Bpsi-mi:“MI:0915”(physical association)0.670
KRT33BKRT78psi-mi:“MI:0915”(physical association)0.630
KRT33BAQP1psi-mi:“MI:0915”(physical association)0.560
ABI2KRT33Bpsi-mi:“MI:0915”(physical association)0.560
AQP1KRT33Bpsi-mi:“MI:0915”(physical association)0.560
KRT33BABI2psi-mi:“MI:0915”(physical association)0.560
KRT33BKRT71psi-mi:“MI:0915”(physical association)0.560

BioGRID (111): KRT33B (Two-hybrid), KRT33B (Two-hybrid), ABI2 (Two-hybrid), KRT79 (Two-hybrid), KRT33B (Affinity Capture-MS), KRT33B (Two-hybrid), KRT33B (Affinity Capture-MS), KRT33B (Affinity Capture-MS), KRT33B (Affinity Capture-MS), KRT33B (Affinity Capture-MS), KRT33B (Affinity Capture-MS), KRT33B (Two-hybrid), KRT33B (Affinity Capture-MS), KRT33B (Two-hybrid), KRT33B (Two-hybrid)

ESM2 similar proteins: A4FUZ0, A5A6M5, A5A6P3, A6QNX5, A7YWK3, B0LKP1, B1AQ75, E1AB55, O43790, O76009, O76013, P02534, P15241, P19013, P25690, P25691, P78385, P78386, P97861, Q0P5J7, Q14525, Q14532, Q14533, Q148H4, Q148H5, Q148H7, Q148H8, Q14CN4, Q15323, Q3SY84, Q497I4, Q61765, Q61897, Q62168, Q6IG03, Q6IG04, Q6IME9, Q6IMF0, Q6NXH9, Q86Y46

Diamond homologs: A1KQY9, A1L317, A1L595, A5A6M0, A5A6M5, A5A6N2, A5A6P3, A6BLY7, A6QQQ9, A7YWM2, B0LKP1, B1AQ75, O57607, O57611, O76009, O76013, O77727, O93256, P02533, P02534, P02535, P02537, P05781, P05783, P05784, P06394, P08727, P08728, P08730, P08777, P08778, P08779, P08802, P13645, P13646, P19001, P19012, P25030, P25690, P35527

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 72 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Formation of the cornified envelope1934.1×1e-22
Keratinization1921.6×5e-19

GO biological processes:

GO termPartnersFoldFDR
intermediate filament organization1966.3×8e-28
keratinization1654.3×8e-22

Disease & clinical

Clinical variants and AI predictions

ClinVar

85 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance81
Likely benign3
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

542 predictions. Top by Δscore:

VariantEffectΔscore
17:41364777:A:ACdonor_gain1.0000
17:41364778:C:CCdonor_gain1.0000
17:41364995:TATCG:Tacceptor_gain1.0000
17:41364996:ATCG:Aacceptor_gain1.0000
17:41364997:TCG:Tacceptor_gain1.0000
17:41364998:CG:Cacceptor_gain1.0000
17:41364998:CGC:Cacceptor_gain1.0000
17:41365000:C:Aacceptor_loss1.0000
17:41365000:C:CCacceptor_gain1.0000
17:41365002:G:Cacceptor_gain1.0000
17:41365002:G:GCacceptor_gain1.0000
17:41365005:G:Cacceptor_gain1.0000
17:41365005:G:GCacceptor_gain1.0000
17:41365296:TCGGT:Tacceptor_gain1.0000
17:41365297:CGGT:Cacceptor_gain1.0000
17:41365297:CGGTC:Cacceptor_gain1.0000
17:41365298:GGT:Gacceptor_gain1.0000
17:41365298:GGTC:Gacceptor_loss1.0000
17:41365299:GT:Gacceptor_gain1.0000
17:41365299:GTC:Gacceptor_loss1.0000
17:41365300:TCT:Tacceptor_loss1.0000
17:41365301:C:CCacceptor_gain1.0000
17:41365302:T:Aacceptor_loss1.0000
17:41365307:C:CTacceptor_gain1.0000
17:41365310:C:CTacceptor_gain1.0000
17:41365311:C:CTacceptor_gain1.0000
17:41365311:C:Tacceptor_gain1.0000
17:41365312:A:Tacceptor_gain1.0000
17:41365388:CCACC:Cdonor_loss1.0000
17:41365417:T:TAdonor_gain1.0000

AlphaMissense

2643 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
17:41369554:C:GR66P0.997
17:41364890:C:GR329P0.992
17:41365194:A:GL286P0.992
17:41369551:A:GL67P0.992
17:41364818:A:GI353T0.991
17:41364902:A:GL325P0.991
17:41364830:A:GL349P0.990
17:41369521:A:GL77P0.990
17:41364800:A:GL359P0.988
17:41364818:A:CI353S0.988
17:41364881:A:GL332P0.988
17:41369413:A:GL113P0.988
17:41369549:C:GA68P0.988
17:41365189:C:GA288P0.987
17:41369555:G:TR66S0.987
17:41369563:A:GL63P0.987
17:41364851:A:GL342P0.986
17:41364872:T:GQ335P0.986
17:41364977:A:GL300P0.986
17:41369539:A:GL71P0.986
17:41369551:A:TL67Q0.986
17:41364806:C:GR357P0.985
17:41364944:A:GL311P0.985
17:41367939:C:GA134P0.985
17:41364810:A:CY356D0.984
17:41364821:T:AE352V0.983
17:41364875:C:GR334P0.983
17:41365227:A:GL275P0.983
17:41369500:A:GL84P0.983
17:41369560:T:AN64I0.983

dbSNP variants (sampled 300 via entrez): RS1001513582 (17:41364885 C>T), RS1001533348 (17:41370098 C>T), RS1001534485 (17:41371770 A>G), RS1001546133 (17:41365070 C>G,T), RS1001847099 (17:41366085 T>C), RS1002279077 (17:41369172 T>C), RS1003282446 (17:41370434 C>A,G), RS1003524738 (17:41367682 T>A,C), RS1003555947 (17:41367945 C>T), RS1003972730 (17:41366034 C>T), RS1004305164 (17:41370386 A>T), RS1004491286 (17:41366524 G>C,T), RS1005084450 (17:41364119 A>G), RS1005103621 (17:41370673 A>G), RS1005609430 (17:41367387 A>G)

Disease associations

OMIM: gene MIM:602762 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

16 total (human), top 16 by PubMed support.

ChemicalActions (top 5)PubMed papers
2-methyl-4-isothiazolin-3-oneincreases expression1
sodium arseniteincreases expression1
potassium chromate(VI)increases expression1
perfluorooctane sulfonic acidincreases expression1
CGP 52608affects binding, increases reaction1
Benzo(a)pyreneincreases methylation1
Diethylhexyl Phthalatedecreases expression1
Estradiolaffects binding, increases reaction1
Folic Aciddecreases expression1
Silicon Dioxideincreases expression1
Smokeincreases expression1
1-Methyl-4-phenylpyridiniumincreases expression1
Asbestos, Crocidoliteincreases expression1
Antirheumatic Agentsincreases expression1
Lactic Aciddecreases expression1
Particulate Matterdecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.